Impact of the COVID-19 pandemic on access to the cerliponase alfa managed access agreement in England for CLN2 treatment

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 4,209 followers.

RT @BattenDiseaseuk: Families took part in this newly published, illuminating study looking at accessing #brineura through Covid-19 @ojrare…

RT @BattenDiseaseuk: Families took part in this newly published, illuminating study looking at accessing #brineura through Covid-19 @ojrare…

Families took part in this newly published, illuminating study looking at accessing #brineura through Covid-19 @ojrarediseases @RD__RP #battendisease https://t.co/jOd00SAvGr

We're published! Our latest study conducted in collaboration with the @BattenDiseaseuk is available to view on the Orphanet Journal of Rare Diseases. https://t.co/TuWabdYEeL @BioMedCentral #Raredisease

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.